[1]Liang XF, Bi SL, Yang WZ, et al.Evaluation of the impact of hepatitis B vaccination among children born between1992and2005in China[J].J Infect Dis, 2009, 200 (1) ∶39-47.
|
[2]陈兴宝, 陈慧芬, Larry Lacey, et al.拉米夫定治疗慢性乙型肝炎病毒感染的经济效益[J].肝脏, 2002, 7 (2) ∶79-81.
|
[3]Cui F, Hadler S, Zheng H, et al.Hepatitis A surveillance and vaccine use in China from1990through2007[J].J Epidemiol, 2009, 19 (4) ∶189-195.
|
[4]Liang XF, Bi SL, Yang WZ, et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J].Vaccine, 2009, 27 (47) ∶6550-6557.
|
[5]崔富强, 卢永, 王富珍, 等.中国乙型病毒性肝炎报告病例构成分析[J].中华流行病学, 2007, 28 (9) ∶872-874.
|
[6] 戴志澄, 祁国明.中国病毒性肝炎血清流行病学调查 (上卷) , 乙型病毒性肝炎的流行特征[M].北京:科学技术文献出版社, 1996.
|
[7]边藏丽, 王华国.6280例体检人员丙型肝炎病毒感染调查分析[J].中国感染控制杂志, 2005, 4 (4) ∶320-322.
|
[8]劳向前, 邵瑞太, 王若涛.戊型肝炎危害状况研究进展[J].中国公共卫生, 2002, 18 (2) ∶243-244.
|
[1] | Shanshan LIU, Xiaohui YU, Jianwei CAI. Changing trend of the disease burden of liver cirrhosis in China from 1990 to 2019[J]. Journal of Clinical Hepatology, 2024, 40(4): 726-733. doi: 10.12449/JCH240414 |
[2] | Huimin LIU, Qing MAO. Research history of hepatitis D in China[J]. Journal of Clinical Hepatology, 2023, 39(4): 742-750. doi: 10.3969/j.issn.1001-5256.2023.04.002 |
[3] | Jie HE, Wanqing CHEN, Hongbing SHEN, Ni LI, Chunfeng QU, Jufang SHI, Feng SUN, Jing JIANG, Guangwen CAO, Guihua ZHUANG, Ji PENG, Expert Panel of China Guideline for Liver Cancer Screening, Working Group of China Guideline for Liver Cancer Screening. China guideline for liver cancer screening (2022, Beijing)[J]. Journal of Clinical Hepatology, 2022, 38(8): 1739-1758. doi: 10.3969/j.issn.1001-5256.2022.08.007 |
[4] | Chen LIANG, Hui LIU, Jie BAI, Yan REN, Tailing WANG, Nianchen LIU, Li BAI, Shuang LIU, Yu CHEN, Zhongping DUAN, Sujun ZHENG. Value of common clinical indices and noninvasive liver fibrosis scores in the diagnosis of advanced liver fibrosis in hepatic-type Wilson's disease in China[J]. Journal of Clinical Hepatology, 2021, 37(3): 570-574. doi: 10.3969/j.issn.1001-5256.2021.03.014 |
[5] | Li LiangLiang, Yu YanYan. Management strategies for patients with chronic viral hepatitis during the coronavirus disease 2019 epidemic[J]. Journal of Clinical Hepatology, 2020, 36(5): 1000-1003. doi: 10.3969/j.issn.1001-5256.2020.05.010 |
[6] | Organ Transplantation Branch, Chinese Medical Doctor Association, Chinese Society of Organ Transplantation, Chinese Medical Association. The Chinese clinical practice guideline on liver transplantation for hepatocellular carcinoma (2018)[J]. Journal of Clinical Hepatology, 2019, 35(2): 275-280. doi: 10.3969/j.issn.1001-5256.2019.02.008 |
[7] | He XiangYi, Shi Jian. Consensus on diagnosis and treatment of chronic cholecystitis and gallstones in China (2018)[J]. Journal of Clinical Hepatology, 2019, 35(6): 1231-1236. doi: 10.3969/j.issn.1001-5256.2019.06.011 |
[8] | Chi XiaoLing, Xiao HuanMing. Traditional Chinese medicine prevention and treatment of liver fibrosis under the new situation of prevention and treatment of viral hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(4): 694-697. doi: 10.3969/j.issn.1001-5256.2018.04.003 |
[10] | Huang JiangWei, Han FangZheng. Research advances in Epstein-Barr viral hepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1333-1337. doi: 10.3969/j.issn.1001-5256.2018.06.043 |
[11] | Chinese Portal Hypertension Diagnosis and Monitoring Study Group (CHESS), Minimally Invasive Intervention Collaborative Group, Chinese Society of Gastroenterology, Emergency Intervention Committee, Chinese College of Interventionalists, et al, . Consensus on clinical application of hepatic venous pressure gradient in China (2018)[J]. Journal of Clinical Hepatology, 2018, 34(12): 2526-2536. doi: 10.3969/j.issn.1001-5256.2018.12.008 |
[12] | Han Shuai, Zhang Ye. Research advances in neurological complications of viral hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(6): 1161-1164. doi: 10.3969/j.issn.1001-5256.2017.06.031 |
[13] | Wang YiPeng, Sun LiMei, Liu YanMin, Zhang Xin, Zhang HaiPing, Zhao DanTong, Yan HuiPing. Analysis of serological characteristics in viral hepatitis patients with positive AMA-M2[J]. Journal of Clinical Hepatology, 2015, 31(8): 1278-1282. doi: 10.3969/j.issn.1001-5256.2015.08.023 |
[14] | Editorial Board of Chinese Journal of Digestion. Chinese consensus on the medical diagnosis and treatment of chronic cholecystitis and gallstones (2014, Shanghai)[J]. Journal of Clinical Hepatology, 2015, 31(1): 7-11. doi: 10.3969/j.issn.1001-5256.2015.01.002 |
[15] | Jiang Ni, Mao XiaoRong, Peng XueBin, Li YueYue, Chen QiMing, Chen QingFeng. Analysis of factors influencing hepatitis C with thyroid dysfunction in Chinese patients[J]. Journal of Clinical Hepatology, 2015, 31(8): 1266-1270. doi: 10.3969/j.issn.1001-5256.2015.08.020 |
[16] | Liu HuiYuan, Ying RuoSu, Chen ZhiMin, Liao BaoLin, Xu Min. Analysis of clinical characteristics of viral hepatitis in pregnant women[J]. Journal of Clinical Hepatology, 2014, 30(11): 1176-1178. doi: 10.3969/j.issn.1001-5256.2014.11.021 |
[17] | He ShuPing, Liang Qin, Zhao Zhen. Changing process and development trend of deaths ( mortality) in patients with viral hepatitis in China[J]. Journal of Clinical Hepatology, 2014, 30(9): 899-902. doi: 10.3969/j.issn.1001-5256.2014.09.-015 |
[18] | Zhu LiHui, Zhang Li, Li GuoQing, Wang ZhengGen. The short - term clinical effect of dexamethasone therapy in the early stage of viral hepatitis patients with heavy tendency[J]. Journal of Clinical Hepatology, 2011, 27(12): 1305-1307. |
[19] | Hu MingFen, Li YunLi, Bo BaoLi, Pang XingMei, Zhuang Lin. Clinical analysis of viral hepatitis complicated with myocardial injury[J]. Journal of Clinical Hepatology, 2011, 27(12): 1301-1304. |
[20] | Wang Yan, Jia JiDong. The progress and challenge of combating HBV infection in Chinese mainland[J]. Journal of Clinical Hepatology, 2010, 26(4): 341-343. |